CABN/CVV: I am always looking for ways to invest in Graphene but CABN looks like an investor trap. Billions in dilution is coming and it appears they still have no cash/product.
CVV already produces/sells the CVD product they are trying to develop... It might be worth a trade here and there, but i would not hold long...
From the filing....
Conversion price for the debt = $0.00045 - $0.00091
The value of the derivative liability balance at September 30, 2014 was $16,187,664. These assumptions are subject to significant changes and market fluctuations from period to period; therefore, the estimated fair value of the derivative liability will fluctuate from period to period and the fluctuation may be material. Based on the assumptions used to estimate the fair value of the derivate liability at September 30, 2014 and assuming all lenders convert the notes payable at the September 30, 2014 conversion prices, the Company would have insufficient authorized shares of common stock to complete the debt conversions.
The authorized share limit is currently 1 billion and it is not enough.
My postings contain many opinions. So please do your own research
and validation.
